Medical Marijuana, Inc. Kannaway® subsidiary celebrates

SAN DIEGO, CA, May 31, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched The world’s first-ever cannabis-derived nutraceutical products, brands and supply chains, today announced that they applauded the Ninth United States Circuit Court of Appeals for ruling on Delta-8 THC, a compound found in hemp, as federally legal under the 2018 Farm Bill.

To celebrate this announcement, Kannaway®, a leader in the cannabis industry for over 12 years, continues to expand its line of hemp-derived products with new Delta-8 Liquid and Delta-8 Gummies. Delta-8 THC is a naturally occurring cannabinoid found in the hemp plant, and new studies show that it may provide users with a variety of unique wellness benefits.

The Ninth Circuit’s ruling is great news for the industry and Kannaway®, as there has been significant consumer interest in this hemp compound in recent years, and analysts predict that Delta-8 THC products could become the fastest growing segment of “hemp derivatives”. product market. According to The Brightfield Group, social listening data shows online conversations about Delta-8 increased 163% from December 2020 to April 2021.

“The 2018 Farm Bill made it clear that hemp with a THC level below 0.3% is federally legal,” said Medical Marijuana, Inc. CEO Blake Schroeder. “As the creators of the world’s first cannabidiol product, we are proud of our accomplishments and the clarity provided by the Farm Bill. We commend the Ninth Circuit for their decision to correctly apply Farm Bill language to Delta-8. As an innovation leader in the industry, enabling free access to all legal cannabinoids is something we celebrate, and we are excited about our new Delta-8 products.

To learn more about these products, please visit

About Kannaway®

Kannaway® is a network sales and marketing company specializing in the sale and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, providing unique insight and opportunities for sales professionals who want to become successful leaders in the sale and marketing of botanicals. of hemp.

About Medical Marijuana, Inc.

We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct non-psychoactive cannabinoid business units: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in providing the highest quality non-psychoactive legal cannabis products derived from industrial hemp; and a clinical research and development sector for cannabinoid-based botanical drugs led by its pharmaceutical investment companies and partners, including AXIM® Biotechnologies, Inc. and Neuropathix. Medical Marijuana, Inc. has been named one of CNBC’s Top CBD Producers. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a leader in developing international markets. The company’s flagship product, Real Scientific Hemp Oil, has been used in several successful clinical studies in Mexico and Brazil to understand its safety and efficacy.

Medical Marijuana, Inc. is headquartered in San Diego, CA, and additional information is available at or by visiting To view the Medical Marijuana, Inc. corporate video, click here.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor created by these articles. This document contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. These forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to differ materially from the statements made herein.


These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.


Medical Marijuana, Inc. does not sell or distribute products that violate the US Controlled Substances Act.

Public relations contact:
Katherine Brown
Account director
CMW Media
[email protected]

Contact with Investor Relations:
T. (858) 283-4016
[email protected]

Comments are closed.